Analyst Randall Stanicky works at RBC and is focused on the Healthcare sector with 550 price targets and ratings documented since 2012 spanning on 24 stocks. Analyst's average stock valuation to be materialised ratio is 46.84% with an average time for price targets to be met of 202.77 days.
Most recent stock forecast was given on ABBV, AbbVie Inc at 07-Apr-2021.
Randall Stanicky best performing recommendations are on EGRX (EAGLE PHARMACEUTICALS, INC).
The best stock recommendation documented was for EGRX (EAGLE PHARMACEUTICALS, INC) at 5/9/2017. The price target of $94 was fulfilled within 1 day with a profit of $4.91 (5.51%) receiving and performance score of 55.11.
Average potential price target upside
Currently, out of the existing stock ratings of Randall Stanicky - 13827 which are a Hold (35.9%), 23639 which are a Buy (61.37%), 1052 which are a Sell (2.73%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
172
$13.75 (8.69%)
166
28 days ago
23/24 (95.83%)
$22.93 (27.45%)
344
Sell
153
$-5.25 (-3.32%)
135
1 months 19 days ago
20/20 (100%)
$19.5 (30.42%)
515
Buy
163
$4.75 (3.00%)
157
1 months 19 days ago
34/35 (97.14%)
$24.2 (28.52%)
414
Sell
153
$-5.25 (-3.32%)
92
1 months 19 days ago
6/6 (100%)
$25.57 (55.74%)
574
Hold
154
$-4.25 (-2.69%)
157
1 months 19 days ago
4/4 (100%)
$15.03 (18.69%)
198